Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient: Case report

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 173-179

  Hill, G R ^a,b   Tey, S K ^a,b   Beagley, L ^a   Crough, T ^a   Morton, J A ^b   Clouston, A D ^c   Whiting, P ^d   Khanna, R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c Department of Envoi Pathology ^*  (Australia)

^d Greenslopes Specialist Centre   (Australia)

Author keywords

CMV disease; Immunotherapy; Stem cell transplant; T cells

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOSCARNET; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THALIDOMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BRONCHIOLITIS OBLITERANS; CANCER REGRESSION; CASE REPORT; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; COLONOSCOPY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LICHENOID; LIVER DISEASE; LIVER FUNCTION; LOCALIZED SCLERODERMA; LONG TERM CARE; LOW DRUG DOSE; MALE; MOUTH PLAQUE; NAUSEA; NEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; STEM CELL EXPANSION; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS REPLICATION; WEIGHT REDUCTION; WHOLE BODY RADIATION;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BASE SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA PRIMERS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIRAL PROTEINS;

EID: 72549090863     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02872.x     Document Type: Article

References (15)

1. Gerna G, Lilleri D, Caldera D, Furione M, Zenone Bragotti L, Alessandrino EP. Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008 41 : 873 879.
2. Gandhi MK, Khanna R. Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004 4 : 725 738.
3. Boeckh M, Fries B, Nichols WG. Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation. Pediatr Transplant 2004 8 (Suppl 5 19 27.
4. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003 9 : 543 558.
5. Zaia JA. Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. Clin Infect Dis 2002 35 : 999 1004.
6. Boeckh M, Leisenring W, Riddell SR et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood 2003 101 : 407 414.
7. Peggs KS, Verfuerth S, Pizzey A et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 2003 362 : 1375 1377.
8. Cobbold M, Khan N, Pourgheysari B et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005 202 : 379 386.
9. Elkington R, Walker S, Crough T et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003 77 : 5226 5240.
10. Smith C, Beagley L, Khanna R. Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression. J Virol 2009 83 : 6192 6198.
11. Walker S, Fazou C, Crough T et al. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transpl Infect Dis 2007 9 : 165 170.
12. Diaz-Mitoma F, Leger C, Miller H et al. Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients. J Clin Microbiol 2003 41 : 5159 5166.
13. Saltzman RL, Quirk MR, Jordan MC. High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J Clin Invest 1992 90 : 1832 1838.
14. Crough T, Khanna R. Immunobiology of human cytomegalovirus: From bench to bedside. Clin Microbiol Rev 2009 22 : 76 98, Table of Contents.
15. Brestrich G, Zwinger S, Fischer A et al. Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy. Am J Transplant 2009 9 : 1679 1684.